Table 2.
Three assessments of blood biochemistry, electrolytes, and coagulation function in ALL and AML patients.
| Variable | First | Second | Third | F (P-value) |
|---|---|---|---|---|
| ALT (IU/L) | ||||
| ALL | 74.5 ± 37.4 | 63.5 ± 26.7 | 48.8 ± 22.1 | 6.14 (0.0031) |
| AML | 79.5 ± 40.2 | 68.6 ± 28.8 | 46.7 ± 20.6 | 4.38 (0.0188) |
| AST (IU/L) | ||||
| ALL | 79.4 ± 65.9 | 53.8 ± 35.3 | 36.4 ± 17.6 | 7.61 (0.0009) |
| AML | 75.2 ± 62.1 | 55.0 ± 37.9 | 35.3 ± 14.1 | 3.26 (0.0482) |
| TBil (μmol/L) | ||||
| ALL | 35.0 ± 15.9 | 29.2 ± 7.7 | 21.3 ± 6.0 | 13.22 (0.0000) |
| AML | 37.8 ± 17.2 | 28.4 ± 8.7 | 22.6 ± 6.3 | 6.44 (0.0036) |
| BUN (mmol/L) | ||||
| ALL | 8.54 ± 2.43 | 7.12 ± 2.19 | 5.33 ± 1.32 | 19.96 (0.0000) |
| AML | 8.40 ± 2.24 | 6.86 ± 2.06 | 5.51 ± 1.49 | 8.20 (0.0010) |
| Creatinine (μmol/L) | ||||
| ALL | 128.9 ± 44.2 | 107.6 ± 32.0 | 78.3 ± 18.4 | 18.68 (0.0000) |
| AML | 124.3 ± 45.8 | 100.7 ± 31.8 | 82.7 ± 19.7 | 5.60 (0.0070) |
| Troponin-I (ng/L) | ||||
| ALL | 2.37 ± 1.64 | 1.85 ± 1.06 | 1.62 ± 0.89 | 3.08 (0.0508) |
| AML | 2.28 ± 1.56 | 1.92 ± 1.13 | 1.61 ± 0.92 | 1.11 (0.3389) |
| CK-MB (μg/L) | ||||
| ALL | 3.42 ± 2.88 | 2.23 ± 1.62 | 1.78 ± 0.85 | 5.92 (0.0038) |
| AML | 3.57 ± 2.60 | 2.58 ± 1.70 | 1.75 ± 0.82 | 3.62 (0.0355) |
| Na+ (mmol/L) | ||||
| ALL | 139.7 ± 3.1 | 140.1 ± 2.5 | 139.9 ± 2.7 | 0.17 (0.8474) |
| AML | 139.3 ± 3.3 | 139.8 ± 2.8 | 140.0 ± 2.6 | 0.23 (0.7959) |
| K+ (mmol/L) | ||||
| ALL | 5.44 ± 0.71 | 4.76 ± 0.57 | 4.42 ± 0.60 | 21.78 (0.0000) |
| AML | 5.38 ± 0.66 | 4.68 ± 0.59 | 4.47 ± 0.63 | 8.65 (0.0007) |
| Ca2+ (mmol/L) | ||||
| ALL | 2.01 ± 0.15 | 1.96 ± 0.11 | 1.95 ± 0.12 | 2.02 (0.1378) |
| AML | 1.99 ± 0.14 | 1.92 ± 0.12 | 1.93 ± 0.10 | 1.47 (0.2424) |
| PT (s) | ||||
| ALL | 13.8 ± 2.5 | 13.3 ± 1.7 | 12.5 ± 0.9 | 4.15 (0.0188) |
| AML | 14.6 ± 2.3 | 13.6 ± 1.6 | 12.7 ± 1.1 | 4.49 (0.0171) |
| APTT (s) | ||||
| ALL | 40.4 ± 8.3 | 36.1 ± 5.1 | 33.3 ± 3.1 | 11.75 (0.0000) |
| AML | 42.8 ± 9.2 | 37.3 ± 6.4 | 34.6 ± 3.5 | 5.70 (0.0065) |
ALL, acute lymphocytic leukemia; AML, acute myeloblastic leukemia; ALT, alanine aminotransferase; AST, aspartate aminotransferase; TBil, total bilirubin; BUN, blood urea nitrogen; CK-MB, creatine kinase; PT, prothrombin time; APTT, activated partial thromboplastin time; ANOVA, analysis of variance.
The results were compared using ANOVA.